Jeremy Fritz stopped working as an assistant manager for a fitness center in Carlsbad, Calif., during the pandemic lockdown in the spring when gyms were first closed. By the end of April, the company operating the fitness center, Active Wellness, eliminated his health insurance. And in July, he was laid off when it became clear…
September 28, 2020 – Beyond the tragic surges in hospitalizations and deaths, the first months of the COVID-19 pandemic disrupted healthcare for people with a wide range of medical conditions – including cancer. For women recovering after breast cancer treatment, COVID-19-related interruptions in rehabilitation care led to emotional distress and other effects on health and…
A new precision drug which stops cancer from repairing its DNA has shown promise in an early-stage clinical trial – highlighting the potential of a new class of drugs known as ATR inhibitors. The drug candidate, tested in humans for the first time, was shown to be well tolerated and stopped the growth of tumours…
September 28, 2020 – A less-invasive treatment technique called hemi-gland cryoablation (HGCryo) – destroying the areas of the prostate where cancers are located by freezing them – provides a high rate of effective prostate cancer control, according to a new study published in The Journal of Urology®, Official Journal of the American Urological Association (AUA).…
In a study published in Autophagy, researchers at the University of Maryland (UMD) shed new light on how Zika virus hijacks our own cellular machinery to break down a protein that is essential for neurological development and cellular communication, getting it to “eat itself”. By triggering this process known as autophagy, Zika virus is able…
INDIANAPOLIS — A new app will allow anyone to contribute real-world data to the effort to understand COVID-19. “MaskCountTM,” from Regenstrief Institute, lets users document the number of people they see wearing or not-wearing masks, all without identifying anyone. This information will be combined for display and analyzed with other COVID-19 data, such as case…
Irvine and Pasadena, CA – Sept. 28, 2020 – Early results of an experimental vaping study have shown significant lung injury from E-cigarette (eC) devices with nickel-chromium alloy heating elements. The findings were consistent, with or without the use of nicotine, vitamin E oil or tetrahydrocannabinol (THC), which have previously been thought to contribute to…
Following two decades of research on a group of rare diseases called hypereosinophilic syndrome at Cincinnati Children’s Hospital Medical Center, the U.S. Food and Drug Administration has approved the drug Nucala (mepolizumab) for use in the treatment of patients with hypereosinophilic syndrome. Hypereosinophilic syndrome, also known as HES, is a life-threatening group of blood disorders…
LOS ANGELES — UCLA researchers have received a $13 million grant from the National Institutes of Health to find new ways to overcome melanoma resistance to some of the most promising targeted therapies and immunotherapies. There have been significant advancements in the past decade using targeted therapies and immunotherapies for treating people with advanced forms…
DES PLAINES, IL — Antacid monotherapy is more effective in relieving epigastric pain than in combination with lidocaine. That is the conclusion of a study to be published in the September 2020 issue of Academic Emergency Medicine (AEM), a journal of the Society for Academic Emergency Medicine (SAEM). The lead author of the single-center study…